Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Gomatou (Athens, Greece), R. Tringidou (Athens, Greece), T. Karampitsakos (Athens, Greece), V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), D. Bouros (Athens, Greece). Subtypes of lung adenocarcinomas associated with IPF. 1310

Member's Comments

No comment yet.

Related content which might interest you: Immunophenotypic profiles of lung carcinomas associated with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Coexistence of COPD in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD Source: Eur Respir J 2014; 43: 1740-1749 Year: 2014 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Epigenetics in IPF and lung cancer Source: Research Seminar 2015 Year: 2015 Treatment and prognosis of lung cancer associated with interstitial pneumonia Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 The prevalence of bronchogenic lung cancer (BLC) in patients with idiopathic pneumonic fibrosis (IPF) Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 Lung cancer and interstitial lung disease Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Distinct forms of BARD1 expressed in lung fibrosis and lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006 Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Lung cancer as a comorbidity in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 PP131 – Macrophages in lung adenocarcinoma Source: ERS Lung Science Conference 2021 Year: 2021 Analysis of the mucus properties in smokers with lung cancer or extra-pulmonary cancer and non smokers with pulmonary metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 The association of lung cancer with pulmonary fibrosis Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021 Year: 2022 Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 How to treat lung cancer in IPF patients Source: Research Seminar 2015 Year: 2015 COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Multiple carcinomas in the lung cancer patients Source: Eur Respir J 2007; 30: Suppl. 51, 671s Year: 2007